Profile data is unavailable for this security.
About the company
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications. The Company’s diversified portfolio includes 28 distinct research and development (R&D) programs, and six clinical trials underway. Its clinical projects include IHL-42X Obstructive Sleep Apnea, IHL-675A Inflammatory Lung Disease, IHL-675A Rheumatoid Arthritis, IHL-675A Inflammatory Bowel Disease, IHL-216A Concussion and TBI, PSI-GAD Psilocybin for anxiety, MedChew GB Post-herpatic Neuralgia and MedChew -1401 Pain and Spasticity in Multiple Sclerosis.
- Revenue in USD (TTM)12.00k
- Net income in USD-18.46m
- Incorporated2023
- Employees9.00
- LocationIncannex Healthcare Inc18 East 50th Street, 5th FloorNEW YORK 10022United StatesUSA
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dare Bioscience Inc | 2.84m | -7.20m | 38.25m | 23.00 | -- | 14.08 | -- | 13.47 | -1.07 | -1.07 | 0.3579 | 0.3126 | 0.1213 | -- | 3.85 | 123,462.20 | -30.76 | -109.51 | -191.39 | -246.26 | 0.8477 | -- | -253.60 | -1,104.55 | -- | -- | 0.00 | -- | -71.92 | -- | 2.54 | -- | 121.37 | -- |
| Earth Science Tech Inc | 20.30m | 1.98m | 38.63m | 32.00 | 19.56 | 12.20 | 18.01 | 1.90 | 0.0064 | 0.0064 | 0.0658 | 0.0103 | 5.40 | 36.44 | -- | 634,456.90 | 52.57 | -37.98 | 77.89 | -- | 69.40 | 63.87 | 9.74 | -15.48 | 1.24 | 3.57 | 0.0261 | -- | 24,526.37 | 73.03 | 322.25 | -- | -- | -- |
| Eyenovia Inc | 31.41k | -37.28m | 40.10m | 57.00 | -- | -- | -- | 1,276.53 | -0.7897 | -0.7897 | 0.0007 | -0.0425 | 0.0013 | -- | 0.0418 | 551.05 | -154.24 | -80.31 | -262.28 | -117.70 | -1,489.11 | -- | -118,693.60 | -680.95 | 0.267 | -40.92 | 1.20 | -- | -- | -- | 2.68 | -- | 152.20 | -- |
| Lexaria Bioscience Corp | 411.01k | -4.85m | 40.32m | 5.00 | -- | 3.61 | -- | 98.09 | -0.4455 | -0.4455 | 0.0408 | 0.6403 | 0.0539 | -- | 2.16 | 82,202.00 | -63.85 | -95.67 | -65.93 | -96.58 | 98.83 | 76.98 | -1,185.15 | -1,612.76 | -- | -64.96 | 0.00 | -- | -11.43 | -12.19 | 8.31 | -- | -- | -- |
| Verrica Pharmaceuticals Inc | 9.21m | -84.99m | 43.86m | 100.00 | -- | -- | -- | 4.76 | -1.83 | -1.83 | 0.1979 | -0.7467 | 0.1416 | 1.67 | 4.67 | 92,100.00 | -130.68 | -55.75 | -174.03 | -78.33 | 74.08 | -- | -922.81 | -754.94 | 1.22 | -10.16 | 3.82 | -- | -43.27 | -- | -173.59 | -- | 5.65 | -- |
| CEL-SCI Corp | 0.00 | -29.10m | 44.28m | 43.00 | -- | 4.61 | -- | -- | -0.5806 | -0.5806 | 0.00 | 0.1562 | 0.00 | -- | -- | -- | -100.88 | -70.19 | -124.78 | -78.31 | -- | -- | -- | -15,434.15 | 0.1793 | -36.79 | 0.5517 | -- | -- | -- | 13.99 | -- | 223.59 | -- |
| United-Guardian, Inc. | 12.31m | 3.25m | 47.51m | 25.00 | 14.64 | 3.92 | 14.18 | 3.86 | 0.7065 | 0.7065 | 2.68 | 2.64 | 0.9575 | 4.12 | 7.65 | 492,387.20 | 25.25 | 29.84 | 28.67 | 34.39 | 50.66 | 55.31 | 26.37 | 28.79 | 6.99 | -- | 0.00 | 97.37 | -14.28 | -4.14 | 0.4616 | -9.92 | 17.19 | -19.73 |
| Fortress Biotech Inc | 82.62m | -49.54m | 48.51m | 186.00 | -- | 2.22 | -- | 0.5871 | -3.71 | -3.71 | 6.05 | 0.7915 | 0.5063 | 2.36 | 6.07 | 444,215.10 | -65.90 | -52.50 | -113.69 | -99.46 | 68.77 | 63.17 | -130.17 | -236.94 | 1.24 | -13.40 | 1.26 | -- | 11.58 | 25.75 | 27.42 | -- | -9.37 | -- |
| Immix Biopharma Inc | 0.00 | -19.02m | 48.59m | 14.00 | -- | 2.03 | -- | -- | -0.8411 | -0.8411 | 0.00 | 0.871 | 0.00 | -- | -- | 0.00 | -86.64 | -- | -100.82 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.44 | -- | -- | -- |
| SCYNEXIS Inc | 8.57m | -36.44m | 48.95m | 29.00 | -- | 0.8363 | -- | 5.71 | -0.756 | -0.756 | 0.177 | 1.54 | 0.0692 | -- | 3.61 | 295,379.30 | -29.44 | -30.02 | -35.54 | -36.35 | -71.42 | -- | -425.41 | -86.76 | -- | -- | 0.1843 | -- | 2,652.72 | 252.64 | 206.74 | -- | -- | -- |
| Odonate Inc | 0.00 | -102.07m | 49.87m | 137.00 | -- | 1,839.01 | -- | -- | -13.59 | -13.59 | 0.00 | 9.27 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
| BGM Group Ltd | 29.87m | -7.86m | 50.66m | 298.00 | -- | 1.15 | -- | 1.70 | -1.10 | -1.10 | 4.18 | 6.07 | 0.5237 | 3.73 | 25.96 | 100,236.40 | -14.43 | 2.71 | -17.01 | 3.86 | 2.92 | 11.66 | -27.56 | 2.72 | 6.06 | -0.7527 | 0.00 | 26.11 | -28.35 | -1.60 | -822.64 | -- | 12.86 | -- |
| Aadi Bioscience Inc | 25.07m | -61.69m | 51.76m | 53.00 | -- | 0.7506 | -- | 2.06 | -2.29 | -2.29 | 0.9285 | 2.80 | 0.2225 | 0.696 | 4.09 | 281,685.40 | -54.75 | -50.25 | -65.27 | -56.15 | 87.39 | -- | -246.06 | -473.97 | 4.54 | -- | 0.00 | -- | 60.06 | 3.85 | -8.68 | -- | 153.54 | -- |
| Incannex Healthcare Inc | 12.00k | -18.46m | 51.87m | 9.00 | -- | 4.16 | -- | 4,322.49 | -1.14 | -1.14 | 0.0007 | 0.7067 | 0.0003 | -- | 0.0024 | 1,333.33 | -48.51 | -130.12 | -54.36 | -148.24 | -- | -- | -153,833.30 | -3,421.98 | -- | -- | 0.00 | -- | -- | 61.03 | 62.18 | -- | 73.79 | -- |
Data as of Nov 12 2024. Currency figures normalised to Incannex Healthcare Inc's reporting currency: US Dollar USD
3.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Tidal Investments LLCas of 30 Jun 2024 | 280.62k | 1.59% |
| AdvisorShares Investments LLCas of 30 Jun 2024 | 80.00k | 0.45% |
| Old Mission Capital LLCas of 30 Jun 2024 | 68.68k | 0.39% |
| HRT Financial LP (US)as of 30 Jun 2024 | 43.93k | 0.25% |
| Morgan Stanley & Co. LLCas of 30 Jun 2024 | 29.85k | 0.17% |
| Barclays Capital Securities Ltd.as of 30 Jun 2024 | 22.50k | 0.13% |
| UBS Securities LLCas of 30 Jun 2024 | 6.00k | 0.03% |
| 1st Capital Management Group GmbHas of 30 Sep 2024 | 800.00 | 0.01% |
| Qube Research & Technologies Ltd.as of 30 Jun 2024 | 717.00 | 0.00% |
| Macquarie Investment Management Business Trustas of 30 Jun 2024 | 598.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
